OSI Jumps on Pancreatic Cancer Trial Shares of OSI Pharmaceuticals Inc. (OSIP.O: Quote, Profile, Research) jumped 13 percent in pre-market trade on Monday after the company #39;s experimental drug was shown to prolong the lives of patients with cancer of the pancreas.